Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STSA
5601
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.68M | ﹤0.01% |
364,785
-22,528
| -6% | -$97.1K |
|
|
CIZ
5602
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $1.68M | ﹤0.01% |
53,629
+34,014
| +173% | +$1M |
|
5603
CALL
Silicon Motion
SIMO
$9.25B
| $1.68M | ﹤0.01% |
34,900
+19,800
| +131% | +$809K |
|
5604
PUT
Cue Biopharma
CUE
$189M
| $1.68M | ﹤0.01% |
+4,473
| New | +$1.79M |
|
5605
iShares Russell 1000 Value ETF
IWD
$84B
| $1.68M | ﹤0.01% |
12,271
-60,017
| -83% | -$7.7M |
|
5606
Oppenheimer Holdings
OPY
$1.27B
| $1.68M | ﹤0.01% |
53,367
+37,620
| +239% | +$1.06M |
|
5607
PUT
Adeia
ADEA
$3.27B
| $1.68M | ﹤0.01% |
302,872
+53,392
| +21% | +$232K |
|
5608
State Street SPDR S&P Software & Services ETF
XSW
$495M
| $1.68M | ﹤0.01% |
+10,869
| New | +$1.46M |
|
5609
PUT
OneSpan
OSPN
$587M
| $1.67M | ﹤0.01% |
80,900
-3,800
| -4% | -$81.7K |
|
|
IPG
5610
CALL
DELISTED
Interpublic Group of Companies
IPG
| $1.67M | ﹤0.01% |
71,100
-34,100
| -32% | -$715K |
|
5611
SFL Corp
SFL
$1.66B
| $1.67M | ﹤0.01% |
266,204
+56,362
| +27% | +$390K |
|
|
AIVC
5612
Amplify Bloomberg AI Equal Weight ETF
AIVC
$135M
| $1.67M | ﹤0.01% |
32,081
+10,637
| +50% | +$494K |
|
5613
PUT
Ashland
ASH
$3.4B
| $1.67M | ﹤0.01% |
21,100
-3,100
| -13% | -$234K |
|
5614
CALL
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$98.8M
| $1.67M | ﹤0.01% |
39,900
+10,800
| +37% | +$389K |
|
|
INCE
5615
Franklin Income Equity Focus ETF
INCE
$282M
| $1.67M | ﹤0.01% |
39,486
-1,432
| -3% | -$58.2K |
|
5616
Xencor
XNCR
$1.72B
| $1.67M | ﹤0.01% |
38,258
+6,175
| +19% | +$255K |
|
|
TIF
5617
PUT
DELISTED
Tiffany & Co.
TIF
| $1.67M | ﹤0.01% |
12,700
-9,300
| -42% | -$1.19M |
|
5618
CALL
Boise Cascade
BCC
$2.86B
| $1.67M | ﹤0.01% |
34,900
+14,300
| +69% | +$621K |
|
5619
Qualys
QLYS
$6.34B
| $1.67M | ﹤0.01% |
13,690
-7,540
| -36% | -$746K |
|
|
ONEM
5620
PUT
DELISTED
1Life Healthcare
ONEM
| $1.67M | ﹤0.01% |
38,200
+8,200
| +27% | +$280K |
|
5621
SITE Centers
SITC
$156M
| $1.67M | ﹤0.01% |
210,944
-5,664,563
| -96% | -$39.5M |
|
|
DCPH
5622
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.67M | ﹤0.01% |
29,200
+4,000
| +16% | +$237K |
|
5623
CALL
Americold
COLD
$4.14B
| $1.67M | ﹤0.01% |
44,600
+37,200
| +503% | +$1.34M |
|
5624
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.17B
| $1.66M | ﹤0.01% |
+23,035
| New | +$1.43M |
|
5625
CALL
Timken Company
TKR
$9.28B
| $1.66M | ﹤0.01% |
21,500
+9,500
| +79% | +$647K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.